Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

The Phase I Trial data will be submitted to regulatory agencies for review for advancing the vaccine into a Phase II efficacy ...